3aiy Citations

Unraveling the symmetry ambiguity in a hexamer: calculation of the R6 human insulin structure.

J Biomol NMR 16 93-108 (2000)
Related entries: 2aiy, 4aiy, 5aiy

Cited: 27 times
EuropePMC logo PMID: 10723989

Abstract

Crystallographic and NMR studies of insulin have revealed a highly flexible molecule with a range of different aggregation and structural states; the importance of these states for the function of the hormone is still unclear. To address this question, we have studied the solution structure of the insulin R6 symmetric hexamer using NMR spectroscopy. Structure determination of symmetric oligomers by NMR is complicated due to 'symmetry ambiguity' between intra- and intermonomer NOEs, and between different classes of intermonomer NOEs. Hence, to date, only two symmetric tetramers and one symmetric pentamer (VTB, B subunit of verotoxin) have been solved by NMR: there has been no other symmetric hexamer or higher-order oligomer. Recently, we reported a solution structure for R6 insulin hexamer. However, in that study, a crystal structure was used as a reference to resolve ambiguities caused by the threefold symmetry; the same method was used in solving VTB. Here, we have successfully recalculated R6 insulin using the symmetry-ADR method, a computational strategy in which ambiguities are resolved using the NMR data alone. Thus the obtained structure is a refinement of the previous R6 solution structure. Correlated motions in the final structural ensemble were analysed using a recently developed principal component method; this suggests the presence of two major conformational substates. The study demonstrates that the solution structure of higher-order symmetric oligomers can be determined unambiguously from NMR data alone, using the symmetry-ADR method. This success bodes well for future NMR studies of higher-order symmetric oligomers. The correlated motions observed in the structural ensemble suggest a new insight into the mechanism of phenol exchange and the T6 <--> R6 transition of insulin in solution.

Articles - 3aiy mentioned but not cited (6)

  1. Comparison of NMR and Dynamic Light Scattering for Measuring Diffusion Coefficients of Formulated Insulin: Implications for Particle Size Distribution Measurements in Drug Products. Patil SM, Keire DA, Chen K. AAPS J 19 1760-1766 (2017)
  2. Hydroxytyrosol Selectively Affects Non-Enzymatic Glycation in Human Insulin and Protects by AGEs Cytotoxicity. Sirangelo I, Borriello M, Liccardo M, Scafuro M, Russo P, Iannuzzi C. Antioxidants (Basel) 10 1127 (2021)
  3. Hydroxytyrosol Inhibits Protein Oligomerization and Amyloid Aggregation in Human Insulin. Sirangelo I, Borriello M, Vilasi S, Iannuzzi C. Int J Mol Sci 21 E4636 (2020)
  4. Synthesis and Structural Characterization of Ricin Inhibitors Targeting Ribosome Binding Using Fragment-Based Methods and Structure-Based Design. Li XP, Harijan RK, Cao B, Kahn JN, Pierce M, Tsymbal AM, Roberge JY, Augeri D, Tumer NE. J Med Chem 64 15334-15348 (2021)
  5. SAXS Reveals the Stabilization Effects of Modified Sugars on Model Proteins. Piccinini A, Lourenço EC, Ascenso OS, Ventura MR, Amenitsch H, Moretti P, Mariani P, Ortore MG, Spinozzi F. Life (Basel) 12 123 (2022)
  6. TXNL1 has dual functions as a redox active thioredoxin-like protein as well as an ATP- and redox-independent chaperone. Andor A, Mohanraj M, Pató ZA, Úri K, Biri-Kovács B, Cheng Q, Arnér ESJ. Redox Biol 67 102897 (2023)


Reviews citing this publication (1)

Articles citing this publication (20)

  1. Traveling-wave ion mobility mass spectrometry of protein complexes: accurate calibrated collision cross-sections of human insulin oligomers. Salbo R, Bush MF, Naver H, Campuzano I, Robinson CV, Pettersson I, Jørgensen TJ, Haselmann KF. Rapid Commun Mass Spectrom 26 1181-1193 (2012)
  2. Breaking symmetry in the structure determination of (large) symmetric protein dimers. Gaponenko V, Altieri AS, Li J, Byrd RA. J Biomol NMR 24 143-148 (2002)
  3. Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects. Shafqat J, Melles E, Sigmundsson K, Johansson BL, Ekberg K, Alvelius G, Henriksson M, Johansson J, Wahren J, Jörnvall H. Cell Mol Life Sci 63 1805-1811 (2006)
  4. Ligand escape pathways and (un)binding free energy calculations for the hexameric insulin-phenol complex. Vashisth H, Abrams CF. Biophys J 95 4193-4204 (2008)
  5. An Achilles' heel in an amyloidogenic protein and its repair: insulin fibrillation and therapeutic design. Yang Y, Petkova A, Huang K, Xu B, Hua QX, Ye IJ, Chu YC, Hu SQ, Phillips NB, Whittaker J, Ismail-Beigi F, Mackin RB, Katsoyannis PG, Tycko R, Weiss MA. J Biol Chem 285 10806-10821 (2010)
  6. A Study of Ion-Neutral Collision Cross Section Values for Low Charge States of Peptides, Proteins, and Peptide/Protein Complexes. Fernandez-Lima FA, Blase RC, Russell DH. Int J Mass Spectrom 298 111-118 (2010)
  7. A new cell secreting insulin. Roy SS, Mukherjee M, Bhattacharya S, Mandal CN, Kumar LR, Dasgupta S, Bandyopadhyay I, Wakabayashi K. Endocrinology 144 1585-1593 (2003)
  8. Influence of different assignment conditions on the determination of symmetric homodimeric structures with ARIA. Bardiaux B, Bernard A, Rieping W, Habeck M, Malliavin TE, Nilges M. Proteins 75 569-585 (2009)
  9. Structure determination of symmetric homo-oligomers by a complete search of symmetry configuration space, using NMR restraints and van der Waals packing. Potluri S, Yan AK, Chou JJ, Donald BR, Bailey-Kellogg C. Proteins 65 203-219 (2006)
  10. Principal components analysis of protein structure ensembles calculated using NMR data. Howe PW. J Biomol NMR 20 61-70 (2001)
  11. An antiparallel four-helix bundle orients the high-affinity RNA binding sites in hnRNP C: a mechanism for RNA chaperonin activity. Shahied L, Braswell EH, LeStourgeon WM, Krezel AM. J Mol Biol 305 817-828 (2001)
  12. A complete algorithm to resolve ambiguity for intersubunit NOE assignment in structure determination of symmetric homo-oligomers. Potluri S, Yan AK, Donald BR, Bailey-Kellogg C. Protein Sci 16 69-81 (2007)
  13. COCO: a simple tool to enrich the representation of conformational variability in NMR structures. Laughton CA, Orozco M, Vranken W. Proteins 75 206-216 (2009)
  14. Development of an intermediate chromatography step in an insulin purification process. The use of a High Throughput Process Development approach based on selectivity parameters. Heldin E, Grönlund S, Shanagar J, Hallgren E, Eriksson K, Xavier M, Tunes H, Vilela L. J Chromatogr B Analyt Technol Biomed Life Sci 973C 126-132 (2014)
  15. Solution structure of the coiled-coil trimerization domain from lung surfactant protein D. Kovacs H, O'Ddonoghue SI, Hoppe HJ, Comfort D, Reid KB, Campbell lD, Nilges M. J Biomol NMR 24 89-102 (2002)
  16. A graphical method for analyzing distance restraints using residual dipolar couplings for structure determination of symmetric protein homo-oligomers. Martin JW, Yan AK, Bailey-Kellogg C, Zhou P, Donald BR. Protein Sci 20 970-985 (2011)
  17. A geometric arrangement algorithm for structure determination of symmetric protein homo-oligomers from NOEs and RDCs. Martin JW, Yan AK, Bailey-Kellogg C, Zhou P, Donald BR. J Comput Biol 18 1507-1523 (2011)
  18. Development of parallel density functional program using distributed matrix to calculate all-electron canonical wavefunction of large molecules. Inaba T, Sato F. J Comput Chem 28 984-995 (2007)
  19. Analysis methods for identifying coordinated movements during ligand unbinding. Chau PL, Howe PW. J Comput Aided Mol Des 16 755-765 (2002)
  20. Evidence of oligomerization of bovine insulin in solution given by NMR. Efimov SV, Zgadzay YO, Tarasova NB, Klochkov VV. Eur Biophys J 47 881-889 (2018)


Related citations provided by authors (2)

  1. Calculation of Symmetric Oligomer Structures from NMR Data. O'Donoghue SI, Nilges M Structure, Computation and Dynamics in Protein NMR (in: Biological Magnetic Resonance, V. 17) - (1999)
  2. Solution Structures of the R6 Human Insulin Hexamer. Chang X, Jorgensen AM, Bardrum P, Led JJ Biochemistry 36 9409- (1997)